Back to Search
GARY HUDES, M.D.
M.D.
Medical Oncology Physician
NPI: 1861455313Individual
Specialties, Licenses & Credentials
Specialist
Specialist
Code: 174400000X
MD024455(PA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD024455E(PA)
Research & Publications (20)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.
PMID 17538086·N Engl J Med·2007
3-trial
Signaling inhibitors in the treatment of prostate cancer.
PMID 12099576·Invest New Drugs·2002
6-review
Phase I clinical and pharmacologic trial of intravenous estramustine phosphate.
PMID 11844837·J Clin Oncol·2002
3-trial
Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.
PMID 10955786·Clin Cancer Res·2000
3-trial
Phase I trial of sunitinib malate plus interferon-alpha for patients with metastatic renal cell carcinoma.
PMID 19213665·Clin Genitourin Cancer·2009
3-trial
Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies.
PMID 19229667·Med Oncol·2009
3-trial
Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference.
PMID 19402064·Cancer·2009
8-other
Analysis of PTEN and HIF-1alpha and correlation with efficacy in patients with advanced renal cell carcinoma treated with temsirolimus versus interferon-alpha.
PMID 19526589·Cancer·2009
3-trial
NCCN clinical practice guidelines in oncology: testicular cancer.
PMID 19555582·J Natl Compr Canc Netw·2009
6-review
The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria.
PMID 19558005·Ann Allergy Asthma Immunol·2009
4-observational
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
PMID 19652060·J Clin Oncol·2009
3-trial
Role of androgen deprivation therapy for node-positive prostate cancer.
PMID 19047295·J Clin Oncol·2009
8-other
NCCN clinical practice guidelines in oncology: kidney cancer.
PMID 19555584·J Natl Compr Canc Netw·2009
6-review
Functional antibody deficiency in a patient with type I Gaucher disease.
PMID 18392747·J Inherit Metab Dis·2008
5-case
Nomograms to predict serious adverse events in phase II clinical trials of molecularly targeted agents.
PMID 18323557·J Clin Oncol·2008
8-other
NCCN Task Force Report: mTOR inhibition in solid tumors.
PMID 18926092·J Natl Compr Canc Netw·2008
6-review
Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study.
PMID 17959415·Lancet Oncol·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 333 COTTMAN AVE, MED STAFF OFFICE
PHILADELPHIA, PA 19111 - Phone
- (215) 728-6900
Quick Facts
- NPI
- 1861455313
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile